Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for UBIS (Asia) PCL's Days Payable or its related term are showing as below:
BKK:UBIS-R'
s Days Payable Range Over the Past 10 Years
Min: 40.41 Med: 58.1 Max: 69.55
Current: 69.55
During the past 13 years, UBIS (Asia) PCL's highest Days Payable was 69.55. The lowest was 40.41. And the median was 58.10.
BKK:UBIS-R's Days Payable is ranked better than 58.32% of 1562
companies
in the Chemicals industry
Industry Median: 59.235
vs BKK:UBIS-R: 69.55
UBIS (Asia) PCL's Days Payable
declined
from Jun. 2025 (80.83) to Jun. 2026 (74.80).
It may suggest that UBIS (Asia) PCLaccelerated paying its suppliers.
The historical data trend for UBIS (Asia) PCL's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:UBIS-R vs LIN, SHW, ECL: Days Payable Comparison
For the Specialty Chemicals subindustry, UBIS (Asia) PCL's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UBIS (Asia) PCL Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, UBIS (Asia) PCL's Days Payable distribution charts can be found below:
* The bar in red indicates where UBIS (Asia) PCL's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
UBIS (Asia) PCL's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UBIS (Asia) PCL (BKK:UBIS-R) has a Days Payable of 74.80 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on UBIS (Asia) PCL and its competitors. This is 29% above median its historical median of 58.10. Over the past decade, UBIS (Asia) PCL's Days Payable has ranged from 40.41 to 69.55. According to the industry distribution chart, UBIS (Asia) PCL ranks #651 out of 1562 companies in the Chemicals industry, placing it in the top 41.7%.
Is UBIS (Asia) PCL's Days Payable too high?
UBIS (Asia) PCL's current Days Payable of 74.80 is 29% above median its 10-year median of 58.10. Over the past 10 years, this metric has ranged from a low of 40.41 to a high of 69.55. The Chemicals industry median Days Payable is 59.24. UBIS (Asia) PCL's value of 74.80 is 26.3% above this industry median. Based on the distribution chart, UBIS (Asia) PCL ranks #651 out of 1562 companies in the Chemicals industry, which is above the industry midpoint. Overall, UBIS (Asia) PCL has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does UBIS (Asia) PCL's Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, UBIS (Asia) PCL ranks #651 out of 1562 companies for Days Payable. This puts UBIS (Asia) PCL in the upper half of its industry. The industry median Days Payable is 59.24. UBIS (Asia) PCL's value of 74.80 is 26.3% above this benchmark. Historically, UBIS (Asia) PCL's own Days Payable has ranged from 40.41 to 69.55 over the past decade. While the company's 10-year median is 58.10 vs. the industry median of 59.24, UBIS (Asia) PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.24, based on 1,562 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UBIS (Asia) PCL's current Days Payable of 74.80 is 26.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on UBIS (Asia) PCL and its competitors. For the Chemicals industry, the median Days Payable is 59.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UBIS (Asia) PCL's current Days Payable is 74.80, which is 29% above median its own 10-year median of 58.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UBIS (Asia) PCL stock overvalued right now?
UBIS (Asia) PCL (BKK:UBIS-R) has a current Days Payable of 74.80. The stock's GF Value™ is ฿1.58, compared to a current price of ฿1.69 — trading 6.9% above its estimated fair value. The current Days Payable is 74.80, which is 29% above median its 10-year median of 58.10 and 26.3% above the Chemicals industry median of 59.24. UBIS (Asia) PCL's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For UBIS (Asia) PCL (BKK:UBIS-R), the current Days Payable is 74.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UBIS (Asia) PCL (BKK:UBIS-R) Overvalued in 2026?
Based on GuruFocus' analysis, UBIS (Asia) PCL stock appears to be overvalued.
The current stock price of ฿1.69 is trading 6.9% above its estimated GF Value™ of ฿1.58.
Key valuation signals for BKK:UBIS-R:
Days Payable: 74.80 (29% above median its 10-year median of 58.10)
GF Value™: ฿1.58 vs. price of ฿1.69 (6.9% above fair value)
Industry Position: 26.3% above the Chemicals median (#651 of 1562)
No single metric tells the full story. See the BKK:UBIS-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UBIS (Asia) PCL is engaged in the business of manufacturing and distributing of sealing compounds, lacquers, and coatings used in can production and bottle closure for the food, beverage, and general industries. It operates in two business segments, each offering different products and services: Manufacturer and distributor of sealing compounds, lacquers and coatings and Other business The majority of the revenue is generated from the Manufacturer of sealing compounds, lacquers and coatings segment. Company operates in Thailand, China, and Others, with the majority of revenue from Other segment.
65GF Score
Get the complete analysis for BKK:UBIS-R
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:UBIS-R has been successfully added to your 
